)
MUHAS in collaboration with SickleInAfrica, Sickle CHARTA, REDAC, ASH-CONSA, PEN-Plus and THE LANCET HAEMATOLOGY will host a Symposium with theme 'From Newborn Screening to Gene Therapy for Sickle Cell Disease: Challenges and Prospects in Africa'.
The Symposium will be hosted at MUHAS, Upanga Campus in Dar-es-salaam, Tanzania on Wednesday 12th - Thursday 13th July 2023 and will be moderated in both English and French. The Symposium will be Hybrid (in-person and virtual).
© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.
ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.
ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.
